Obesity and inflammatory diseases are increasing in prevalence and contribute to the growing burden of lifestyle disorders such as diabetes and hypertension. There is a lack of naturally derived alternatives to tackle these issues. Researchers have synthesized novel amino acid derivatives of menthol and studied its properties.
The menthyl esters showed exceptional anti-inflammatory and anti-obesity activities during preclinical studies and can be developed as therapeutic compounds with further research.
In a recent study, a team of researchers led by Professor Gen-ichiro Arimura from the Department of Biological Science and Technology, Tokyo University of Science, Japan, developed and investigated menthyl esters of valine and isoleucine , which are derived from menthol by replacing its hydroxyl group with valine and isoleucine, respectively.
Elated with their findings, the researchers went a step further and investigated the mechanism of action of the menthyl esters. They discovered that liver X receptor -- an intracellular nuclear receptor, had an important role in the anti-inflammatory effects and this was independent of the cold-sensitive transient receptor TRPM8, which primarily detects menthol.
"Although this study focused on their functions and mechanisms of action in diseases modeled after inflammation and obesity, we expect that these compounds will also be effective against a wide range of lifestyle-related diseases caused by metabolic syndrome, such as diabetes and hypertension, as well as allergic symptoms," says Prof. Arimura optimistically.
Obesity Pharmacology Breast Cancer Diseases And Conditions Birth Defects Immune System Diet And Weight Loss
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Couch potato kids more likely to have heart damageScientists says light physical activity can reverse the risk, say scientists.
Lire la suite »
South Park: The End of Obesity Teaser Trailer Sets Release DateSouth Park is back with another television special, this time in the form of South Park: The End of Obesity, a special about Cartman's weight
Lire la suite »
Cartman Tries Out Ozempic in New 'South Park: The End of Obesity' TrailerCartman holding his belly in South Park: The End of Obesity
Lire la suite »
No, kitty, this is Cartman's Ozempic in South Park: The End Of Obesity trailerWith the prospect of medically suppressed appetite, Eric Cartman stars in South Park: The End Of Obesity
Lire la suite »
South Park Teaser: Could It Be 'The End of Obesity' For Cartman?The advent of new weight loss drugs has a huge impact on everyone in South Park. When Cartman is denied access to the life-changing medicine, the kids jump into action. The new exclusive event SOUTH PARK: THE END OF OBESITY premieres May 24, 2024 on Paramount+! Stream the previous South Park exclusive events on Paramount+: https://bit.
Lire la suite »
Setmelanotide Shows Promise in Hypothalamic ObesityTreatment with setmelanotide, a melanocortin-4 receptor agonist, led to a significant reduction in BMI in a difficult-to-treat population of patients with hypothalamic obesity.
Lire la suite »